Health & Safety Industry Today
AI in Drug Repurposing Market Poised for Transformational Growth, Accelerating Toward USD 6.29 Billion by 2034 at an Impressive 20.1% CAGR
Market Overview
The latest market study published by Polaris Market Research titled AI In Drug Repurposing Market Size, Share, Trends, Industry Analysis Report By Drug Type, By Therapeutic Area, By Deployment Mode, By End User, By Region – Market Forecast, 2025–2034 is designed to provide users with an in-depth understanding of the market. A comprehensive historical analysis of the market is given, along with extensive market forecasts by region/country and subsectors.
The primary objective of this report is to help readers gain insights into AI In Drug Repurposing Market size, trends, sales volume, revenue, historical growth, latest developments, and future outlooks. It offers a qualitative and quantitative analysis of leading participants, expansion plans, geographical regions, and share valuations across all regions.
AI In Drug Repurposing Market Size:
The global AI in drug repurposing market was valued at USD 1.01 billion in 2024 and is growing rapidly as AI helps identify new uses for existing drugs faster and at lower cost. With a strong CAGR of 20.1% from 2025 to 2034, the market is projected to reach USD 6.29 billion by 2034, driven by rising R&D efficiency and faster clinical outcomes.
What Is Aim of This Report?
The purpose of the market research is to get a thorough understanding of the industry's potential and to offer insights that will help businesses make wise decisions. The study is an essential part of the industry analysis that focuses on key dynamics, SWOT analysis, demand-supply scenario, pricing structure, profit margins, production, and value chain analysis. The report analyzes the unique characteristics and behaviors of each segment that assist users in developing targeted marketing strategies that are tailored to the specific needs and preferences of their customers. The study offers a thorough analysis of the AI In Drug Repurposing Market segmentation, including application, product, and service types and several geographic locations.
Get a Sample with the Latest Trends and Future Advancements:
Key Applications
- Identifying new therapeutic uses for existing drugs
- Accelerating drug discovery and clinical trial design
- Predicting drug–disease interactions using machine learning
- Supporting personalized medicine and rare disease treatment
- Reducing failure rates in late-stage drug development
Key Benefits
- Faster drug development timelines
- Lower R&D costs compared to traditional drug discovery
- Improved success rates for clinical trials
- Enables rapid response to emerging diseases
- Maximizes value from approved and shelved drugs
Market Dynamic Factors
This report lists the various actors that have contributed to the market's upward trajectory. In-depth trends and opportunities in the AI In Drug Repurposing Market are highlighted in the analysis. The study report also enables customers to recognize opportunities and difficulties. The research goes on to identify the principal impediments to industry development. Based on the SWOT and Porter's Five Forces models, market dynamics are evaluated, covering the important demand and price variables.
Competitive Landscape Analysis
Another significant portion of this study discusses the competitive landscape of the market. The market's top players are examined in the study. The AI In Drug Repurposing Market key players have been described in terms of their key attributes in the information. The section examines their supply chains, potential for growth, AI In Drug Repurposing Market share, product portfolio, capacity, cost, revenue, capabilities, expansions, investments, mergers and acquisitions, manufacturer advancements, volume, and clientele. Financial and SWOT analysis contribute to a deeper understanding of the market.
List of Major Key Players
- AutoRek
- BlackLine Inc.
- Broadridge Financial Solutions, Inc.
- Calixys
- Entry Inc.
- FloQast
- GSPV Ltd. (Xelix)
- HighRadius
- Kepion Incorporated
For Customization Requests, Please Visit
Segment Insights
AI In Drug Repurposing Market, Drug Type Outlook (Revenue - USD Billion, 2020-2034)
- Small Molecules
- Biologics
- Vaccines
- Peptides
- Others
AI In Drug Repurposing Market, Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)
- Oncology
- Neurology
- Cardiovascular Diseases
- Infectious Diseases
- Immunology
- Metabolic Disorders
- Rare Diseases
- Others
AI In Drug Repurposing Market, End User Outlook (Revenue - USD Billion, 2020-2034)
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Healthcare Providers
- Others
AI In Drug Repurposing Market, Deployment Mode Outlook (Revenue - USD Billion, 2020-2034)
- Cloud-based
- On-premises
Regional Analysis
Further, the report goes on to discuss how the AI In Drug Repurposing Market has grown internationally and across various sectors and regions. The regional analysis included in the study provides information at the regional as well as national level by several market segments. Additionally, the study includes information on the origins of raw materials, downstream consumers, and industrial chain analyses. The forecast analysis section includes vital information on global production and revenue projection, as well as regional forecasts.
Browse More Information:
https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-repurposing-market
The Report Provides You Answer to Below Mentioned Question
Q: How does AI improve the drug repurposing process?
Ans: AI analyzes vast biomedical data to quickly identify new therapeutic uses for existing drugs, reducing time and cost compared to traditional research methods.
Q: Why is AI-based drug repurposing gaining popularity?
Ans: It shortens development timelines, lowers R&D risks, and increases success rates by using data-driven predictions instead of trial-and-error approaches.
Q: Which industries benefit most from AI in drug repurposing?
Ans: Pharmaceutical companies, biotechnology firms, academic research institutions, and healthcare providers benefit significantly.
Q: Can AI help in treating rare and emerging diseases?
Ans: Yes, AI can rapidly analyze limited data sets to find viable drug candidates, making it especially useful for rare and newly emerging diseases.
Q: What role does machine learning play in this market?
Ans: Machine learning models identify patterns in drug–disease interactions, enabling accurate prediction of drug effectiveness.
Report Summary
Moreover, a new task SWOT analysis, a venture attainability investigation, and a venture return analysis are all determined by the study. Overall, the report promises to be a reliable resource for choosing the market research that can boost your company. The study also includes a development strategy for the industry, research findings, an appendix, and a conclusion. It also highlights the most recent advancements in the AI In Drug Repurposing Market.
More Related Reports:
Social Platforms for Commerce Market
Hybrid VLM+LLM Controller Market
Europe Ostomy Care And Accessories Market
Carbon Capture and Storage Market
Europe Plant-Based Meat Market
About Polaris Market Research & Consulting, Inc.
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Share on Social Media
Contact Information
Sheetal Gajbhiye
Polaris Market Research & Consulting, Inc.
8 The Green Ste 19824,
Dover, DE
19901
+1 929-297-9727 (US)
https://www.polarismarketresearch.com/
Other Industry News
Ready to start publishing
Sign Up today!
